Cited by 29

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Fasting-induced adipose factor/angiopoietin–like protein 4: a potential target for dyslipidemia?

Zandbergen, Fokko, van Dijk, Susan, Müller, Michael, Kersten, Sander·2006·Future Lipidology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2217/17460875.1.2.227

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ANGPTL4 is robustly expressed in the liver in mice, and in humans liver is the tissue with greatest ANGPTL4 expression.

    “ANGPTL4 is robustly expressed in the liver in mice, and in humans liver is the tissue with greatest ANGPTL4 expression (86, 87).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. Kersten S, Mandard S, Tan NS et al.: Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275, 28488-28493 (2000). · DOI · Paper page
  2. Kim I, Kim HG, Kim H et al.: Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346, 603-610 (2000). · DOI
  3. Yoon JC, Chickering TW, Rosen ED et al.: Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin related protein associated with adipose differentiation. Mol. Cell.Biol. 20, 534-5349 (2000). · DOI · Paper page
  4. Yoshida K, Shimizugawa T, Ono M, Furukawa H: Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43, 1770-1772 (2002). · DOI · Paper page
  5. Davis S, Aldrich TH, Jones PF et al.: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169 (1996). · DOI · Paper page
  6. Maisonpierre PC, Suri C, Jones PF et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60 (1997). · DOI · Paper page
  7. Su AI, Cooke MP, Ching KA et al.: Largescale analysis of the human and mouse transcriptomes. Proc. Natl Acad. Sci. USA 99, 4465-4470 (2002). · DOI · Paper page
  8. Kaplan R, Zhang T, Hernandez M et al.: Regulation of the angiopoietin-like protein 3 gene by LXR. J. Lipid Res. 44, 136-143 (2003). · DOI · Paper page
  9. Lehmann JM, Kliewer SA, Moore LB et al.: Activation of the nuclear receptor by LXR oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137-3140 (1997). · DOI · Paper page
  10. Koishi R, Ando Y, Ono M et al.: ANGPTL3 regulates lipid metabolism in mice. Nature Genet. 30, 151-157 (2002). · DOI · Paper page
  11. Shimizugawa T, Ono M, Shimamura M et al.: ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277, 33742-33748 (2002). · DOI · Paper page
  12. Shimamura M, Matsuda M, Kobayashi S et al.: Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem. Biophys. Res. Commun. 301, 604-609 (2003). · DOI
  13. Oike Y, Akao M, Yasunaga K et al.: Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nature Med. 11, 400-408 (2005). · DOI · Paper page
  14. Backhed F, Ding H, Wang T et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718-15723 (2004). · DOI · Paper page
  15. Ge H, Yang G, Huang L, Motola DL, Pourbahrami T, Li C: Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 279, 2038-2045 (2004). · DOI · Paper page
  16. Mandard S, Zandbergen F, Tan NS et al.: The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279, 34411-34420 (2004). · DOI · Paper page
  17. Ge H, Cha JY, Gopal H et al.: Differential regulation and properties of angiopoietin-like proteins 3 and 4. J. Lipid Res. 46, 1484-1490 (2005). · DOI · Paper page
  18. Yu X, Burgess SC, Ge H et al.: Inhibition of cardiac lipoprotein utilization by transgenic overexpression of ANGPTL4 in the heart. Proc. Natl Acad. Sci. USA 102, 1767-1772 (2005). · DOI · Paper page
  19. Schmuth M, Haqq CM, Cairns WJ et al.: Peroxisome proliferator-activated receptor (PPAR)-γ/δ stimulates differentiation and lipid accumulation in keratinocytes. J. Invest. Dermatol. 122, 971-983 (2004). · DOI
  20. Patsouris D, Mandard S, Voshol PJ et al.: PPARαgoverns glycerol metabolism. J. Clin. Invest. 114, 94-103 (2004). · DOI
  21. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM et al.: PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a in PPRE the lipoprotein lipase gene. EMBO J. 15, 5336-5348 (1996). · DOI · Paper page
  22. Le Jan S, Amy C, Cazes A et al.: Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162, 1521-1528 (2003). · DOI
  23. Wiesner G, Morash BA, Ur E, Wilkinson M: Food restriction regulates adipose-specific cytokines in pituitary gland but not in hypothalamus. J. Endocrinol. 180, R1-R6 (2004). · DOI
  24. Ge H, Yang G, Yu X, Pourbahrami T, Li C: Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J. Lipid Res. 45, 2071-2079 (2004). · DOI · Paper page
  25. Xu A, Lam MC, Chan KW et al.: Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc. Natl Acad. Sci. USA 102, 6086-6091 (2005). · DOI · Paper page
  26. Mandard S, Zandbergen F, van Straten E et al.: The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281, 934-944 (2006). · DOI · Paper page
  27. Oike Y, Ito Y, Maekawa H et al.: Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 103, 3760-3765 (2004). · DOI
  28. Camenisch G, Pisabarro MT, Sherman D et al.: ANGPTL3 stimulates endothelial cell adhesion and migration via integrin αvβ3 and induces blood vessel formation in vivo.J. Biol. Chem. 277, 17281-17290 (2002). · DOI
  29. 33. Hermann LM, Pinkerton M, Jennings K et al.: Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin. Immunol. 115, 93-101 (2005). · DOI
  30. Stull RA, Tavassoli R, Kennedy S et al.: Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors. Genomics BMC 6, 55 (2005). · DOI
  31. Ifon ET, Pang AL, Johnson W et al.: U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int. 5, 19 (2005). · DOI
  32. Arao T, Yanagihara K, Takigahira M et al.: ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int. J. Cancer 118, 483-489 (2006). · DOI
  33. Minn AJ, Gupta GP, Siegel PM et al.: Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Zandbergen, F., van Dijk, S., Müller, M., & Kersten, S.
Affiliations
  • University of Alabama at Birmingham, Department of Pathology, Center for Free Radical Biology, USA
  • Biomedical Research Building II, 901 19th Street, South Birmingham, Alabama, 35294-2180, USA, Tel.: ; Fax.: ,
Venue
Future Lipidology
Published
2006-04-01
Volume
1
Issue
2
Pages
227-236
ISSN
1746-0875
Cited by
29
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review